Tissue and Organ Transplantation Market, by Product Type (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Application (Organ Transplantation and Tissue Transplantation ), by End User (Hospital, Transplant Centers, and Others), and

Tissue and Organ Transplantation Market, by Product Type (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Application (Organ Transplantation and Tissue Transplantation ), by End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Transplantation is a complex area of medicine because when organs or tissues are transplanted from one person to another, the recipient’s immune system can reject and destroy the donor organ or tissue and medication would be needed to suppress this immune response.
Organ transplantation is the surgical operation carried out for replacement of damaged organ of an individual. Donated organs are obtained from living donor, deceased donor or from an animal. Whereas in some cases, an artificial organ is used for the transplantation procedure.
Market Dynamics
The global tissue and organ transplantation market is expected to witness significant growth during the forecast period, owing to the technological advancements in transplantation procedures. For instance, in May 2016, Immucor, Inc., a global leader in transfusion and transplantation diagnostics, launched kidney Solid Organ Response Test, kSORT. It is a molecular gene expression assay that measures a kidney recipient’s immune response to predict organ rejection and graft injury.
Key features of the study:
This report provides in-depth analysis of the global tissue and organ transplantation market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global tissue and organ transplantation market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include CryoLife, Inc., Folio Biosciences, Arthrex, AbbVie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, Biolife Solutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological up gradation, market expansion, and marketing tactics
The global tissue and organ transplantation market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the tissue and organ transplantation market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Tissue and Organ Transplantation Market, By Product Type:
Tissue Products
Preservation Solution
Immunosuppressive Drugs
Global Tissue and Organ Transplantation Market, By Application:
Organ Transplantation
Tissue Transplantation
Global Tissue and Organ Transplantation Market, By End User:
Hospital
Transplant Centers
Others
Global Tissue and Organ Transplantation Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Tissue Products
Preservation Solution
Immunosuppressive Drugs
By Application
Organ Transplantation
Tissue Transplantation
By End User:
Hospital
Transplant Centers
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Tissue Products
Preservation Solution
Immunosuppressive Drugs
By Application
Organ Transplantation
Tissue Transplantation
By End User:
Hospital
Transplant Centers
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Tissue Products
Preservation Solution
Immunosuppressive Drugs
By Application
Organ Transplantation
Tissue Transplantation
By End User:
Hospital
Transplant Centers
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Tissue Products
Preservation Solution
Immunosuppressive Drugs
By Application
Organ Transplantation
Tissue Transplantation
By End User:
Hospital
Transplant Centers
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Tissue Products
Preservation Solution
Immunosuppressive Drugs
By Application
Organ Transplantation
Tissue Transplantation
By End User:
Hospital
Transplant Centers
Others
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Product Type:
Tissue Products
Preservation Solution
Immunosuppressive Drugs
By Application
Organ Transplantation
Tissue Transplantation
By End User:
Hospital
Transplant Centers
Others
Company Profiles
CryoLife, Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Folio Biosciences
Arthrex
Abbvie, Inc.
Zimmer Biomet
Medtronic PLC
Novartis AG
Stryker Corporation
BiolifeSolutions, Inc.
Teva Pharmaceuticals
Veloxis Pharmaceutical

“*” marked represents similar segmentation in other categories in the respective section.